Primary Record
OXYTOCIN
- In stock
- 2,686 g
- Purity
- 98.4 %
- CAS
- 50-56-6
Compound Identifiers & Properties
- CAS
- 50-56-6
- PubChem CID
- 439302
- SMILES
- CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
- Canonical SMILES
- CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O
Names & Synonyms
- OXYTOCIN
- Pitocin
- Endopituitrina
- Syntocinon
- Ocytocin
- Oxytocinum
- Oxitocina
- Oxytocine
- Orasthin
- Oxystin
- Syntocinone
- Partocon
- Presoxin
- Syntocin
- Uteracon
- alpha-Hypophamine
- Di-sipidin
- Synthetic oxytocin
- Piton S
- Nobitocin S
- Ocytocinum
- Ossitocina
- Oxetakain
- Synpitan
- Oxoject
- Oxtocin
- Utedrin
- 50-56-6
- Atonin O
- Intertocine S
- perlacton
- (1-Hemicystine)oxytocin
- Vasotocin;
- [3H]oxytocin
- Oxytocic hormone
- Oxytocin acetate
- Oxytocin-
- Oxetakain [Czech]
- |A-Hypophamine
- Oxytocin RS
- Oxytocin CRS
- Nobitocin S.
- Ossitocina [DCIT]
- Syntocinon (TN)
- Oxytocin Injectable
- Atonin O;
- Oxytocin (TN)
- Pitocin (TN)
- Recombinant Oxytocin
- CYIQNCPLG
- Posterior pituitary extract
- Oxytocin (free acid)
- Oxytocine [INN-French]
- Oxytocinum [INN-Latin]
- oxytocin, for bioassay
- Oxitocina [INN-Spanish]
- RefChem:6091
- 3-Isoleucine-8-leucine vasopressin
- PVL Oxytocin Injectable
- UNII-1JQS135EYN
- 1JQS135EYN
- DTXSID8048361
- D0M3FJ
- D0T6FH
- C43H66N12O12S2
- CHEBI:7872
- CHEMBL395429
- XNOPRXBHLZRZKH-DSZYJQQASA-N
- SCHEMBL29048
- [3H]OT (human, mouse, rat)
- HSDB 2182
- Oxytocin [USP:INN:BAN:JAN]
- Oxytocin (JP18/USP/INN)
- TNX1900
- TTA-121
- Alpha-Hypophamine; Syntocinon;
- MFCD00076731
- GTPL2174
- GTPL2176
- orb1302159
- Oxytocin (High Potency Powder)
- DTXCID4028335
- SCHEMBL27648974
- TNX-1900
- BCBcMAP01_000094
- EINECS 200-048-4
- H01BB02
- Oxytocin [USAN:BAN:INN:JAN]
- Oxytocin [USAN:INN:BAN:JAN]
- WZG0206
- A-HYPOPHAMINEOXYTOCICHORMONE
- AC1L9735
- AMY25364
- MSK10463
- Vasopressin, 3-L-isoleucine-8-L-leucine-
- BRN 3586108
- Oxytocin (Label Under Distributors)
- BDBM50205990
- CID439302
- HB2929
- TI-001
- OXYTOCIN 5 USP UNITS IN DEXTROSE 5%
- AKOS015994657
- BAT-010142
- CID:439302
- CS-3115
- FO35402
- HS-2021
- OXYTOCIN 10 USP UNITS IN DEXTROSE 5%
- OXYTOCIN 20 USP UNITS IN DEXTROSE 5%
- ane-4-carbonyl)pyrrolidine-2-carboxamide
- NCGC00167132-01
- AC-28730
- BP-50422
- HY-17571
- SID:53837750
- SY102952
- C43-H66-N12-O12-S2
- AB0007936
- Oxytocin (intranasal/ muco system, autism)
- B4723
- 6369-EP2272841A1
- 6369-EP2292621A1
- 6369-EP2301936A1
- 6369-EP2308479A2
- 6369-EP2311811A1
- C00746
- D00089
- SBI-0654087.0001
- 076O731
- A828179
- D010121
- Q169960
- SR-01000945111
- (2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide
- Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2, cyclic 1-6 disulfide
- SR-01000945111-1
- BRD-K25243230-001-01-2
- OT
- Oxytocin, European Pharmacopoeia (EP) Reference Standard
- (Gly-9 = C-terminal amide, disulfide bridge between 1 - 6)
- 5,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicos
- L-Cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic (1-->6)-disulfide
- L-Cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic (1-6)-disulfide
- OXT
- Oxytocin, United States Pharmacopeia (USP) Reference Standard
- Oxytocin-(leucine-5,5,5-d3, glycine-2,2-d2) trifluoroacetate salt
- 1-({(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-(4-hydroxybenzyl)-13-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-L-prolyl-L-leucylglycinamide
- L-Cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic(1-6)-disulfide
- Oxytocin, lyophilized powder, ~15 IU/mg solid (Prepared from synthetic oxytocin)
- (2S)-1-((4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-((2S)-butan-2-yl)-16-((4-hydroxyphenyl)methyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl)-N-((2S)-1-((2-amino-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)pyrrolidine-2-carboxamide
- (2S)-1-((4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-((2S)-butan-2-yl)-16-((4-hydroxyphenyl)methyl)-6,9,12,15,18-pentaoxo1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl)-N-((2S)-1-((2-amino-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)pyrrolidine-2-carboxamide
- (2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide
- (2S)-1-[[(4R,7S,10S,13S,16S,19R)-19-azanyl-7-(2-azanyl-2-oxidanylidene-ethyl)-10-(3-azanyl-3-oxidanylidene-propyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentakis(oxidanylidene)-1,2-dithia-5,8,11,14,17-pentazacycloicos-4-yl]carbonyl]-N-[(2S)-1-[(2-azanyl-2-oxidanylidene-ethyl)amino]-4-methyl-1-oxidanylidene-pentan-2-yl]pyrrolidine-2-carboxamide
- (S)-N-((S)-1-((2-amino-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)-1-((4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-((S)-sec-butyl)-16-(4-hydrox
- (S)-N-((S)-1-((2-amino-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)-1-((4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-((S)-sec-butyl)-16-(4-hydroxybenzyl)-6,9,12,1
- (S)-N-((S)-1-((2-amino-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)-1-((4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-((S)-sec-butyl)-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicos
- (S)-N-((S)-1-((2-Amino-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)-1-((4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-((S)-sec-butyl)-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)pyrrolidine-2-carboxamide
- 1-(((4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-(4-hydroxybenzyl)-13-((1S)-1-methylpropyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl)carbonyl)-L-prolyl-L-leucylglycinamide
- 1-{(4R,7S,10S,13S,16S,19R)-19-Amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl}-L-prolyl-L-leucylglycinamide
- 200-048-4
- 4248-64-0
- L-Cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic (1 inverted exclamation marku6)-disulfide
- Otx
- Oxytocin; l-Cysteinyl-l-tyrosyl-l-isoleucyl-l-glutamyl-l-asparaginyl-l-cysteinyl-l-prolyl-l-leucylglycinamide cyclic (1?6)-disulfide; 1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane, cyclic peptide deriv.; 1: PN: WO0178758 SEQID: 1 claimed protein; 1: PN: WO2004000993 PAGE: 53 claimed protein; 1: PN: WO2011145051 SEQID: 1 claimed protein; 3-Isoleucine-8-leucine vasopressin; 74: PN: US20090175821 PAGE: 403 claimed protein; Alpha-hypophamine; Atonin O; Di-sipidin; Endopituitrina; Glycinamide, L-cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucyl-, cyclic (1?6)-disulfide; Hyphotocin; Intertocine S; L-Cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic (1?6)-disulfide; Nobitocin S; Orasthin; Oxystin; Partocon; Perlacton; Pitocin; Piton S; Presoxin; Synpitan; Synpitan forte; Synthetic oxytocin; Syntocin;
- ybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)pyrrolidine-2-carboxamide